<DOC>
	<DOCNO>NCT00077883</DOCNO>
	<brief_summary>The purpose trial study efficacy safety combination TLK286 cisplatin first-line therapy patient locally advanced metastatic non-small cell lung cancer .</brief_summary>
	<brief_title>TLK286 ( Telcyta ) Combination With Cisplatin Locally Advanced Metastatic Non-small Cell Lung Cancer ( NSCLC )</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>18 year age old Histologically confirm nonsmall cell lung cancer Stage IV IIIB Measurable disease RECIST ECOG performance status 01 Adequate liver renal function Adequate bone marrow reserve History bone marrow transplantation stem cell support Pregnant lactating woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2005</verification_date>
</DOC>